Literature DB >> 9395712

Follistatin and its role as an activin-binding protein.

H Sugino1, K Sugino, O Hashimoto, H Shoji, T Nakamura.   

Abstract

Follistatin (FS), a specific binding protein for activin, neutralizes the diverse actions of activin by forming an inactive complex with activin. FS is a monomer derived from two polypeptide core sequences of 288 (FS-288) and 315 (FS-315) amino acids originated from alternatively spliced mRNA. We purified six molecular forms of FS from porcine ovaries. Their structural differences were caused by truncation of the COOH-terminal region and/or the presence of carbohydrate chains, resulting in the formation of FS-288, FS-315 and FS composed of 303 amino acids (FS-303) in various forms of glycosylation on the two potential Asn-linked glycosylation sites. All six molecular species have almost the same activin binding activity (Kd = 540-680 pM). By contrast, the COOH-terminal truncated form, FS-288, showed much higher affinity for heparan sulfate proteoglycans of the cell surface than FS-303, whereas the intact form of FS, FS-315, had no affinity. Furthermore, FS-288 more effectively blocked the suppression of follicle-stimulating hormone (FSH) secretion from rat pituitary cells by activin. This implies that activin binds to the cell surface through FS-288 which adheres to the cell surface. To clarify the physiological role of cell-associated FS, we then investigated the binding of activin to cell-associated FS and the fate of cell surface-bound activin and FS using primary cultured rat pituitary and ovarian granuloma cells. When the cells were incubated with 125I-activin A in the presence of FS-288 or 315, the binding of activin A to the cell surface was promoted much more markedly by FS-288 than by FS-315. The amounts of radioactivity recovered in trichloroacetic acid-soluble fractions (degraded activin) from the incubation medium were greatly increased by the addition of FS-288. This increase was abolished by heparan sulfate, monensin (an endocytosis inhibitor), chloroquine (a lysosome function inhibitor) and several lysosomal enzyme inhibitors. These results suggest that cell-associated FS-288 accelerates the internalization of activin into the cells, leading to its degradation by lysosomal enzymes, and that cell surface-associated FS therefore plays a role in the clearance system of activin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395712

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  12 in total

1.  MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration.

Authors:  Lin Zhang; Maoxian Deng; Ranjani Parthasarathy; Lei Wang; Maureen Mongan; Jeffery D Molkentin; Yi Zheng; Ying Xia
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

Review 2.  The role of activin in mammary gland development and oncogenesis.

Authors:  Karen A Dunphy; Alan L Schneyer; Mary J Hagen; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-08       Impact factor: 2.673

3.  Follistatin regulates germ cell nest breakdown and primordial follicle formation.

Authors:  Fuminori Kimura; Lara M Bonomi; Alan L Schneyer
Journal:  Endocrinology       Date:  2010-11-24       Impact factor: 4.736

Review 4.  Clinical and Therapeutic Implications of Follistatin in Solid Tumours.

Authors:  Lei Shi; Jeyna Resaul; Sioned Owen; Lin Ye; Wen G Jiang
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

Review 5.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

Review 6.  The biology of activin: recent advances in structure, regulation and function.

Authors:  Yin Xia; Alan L Schneyer
Journal:  J Endocrinol       Date:  2009-03-09       Impact factor: 4.286

7.  Pathway for polyarginine entry into mammalian cells.

Authors:  Stephen M Fuchs; Ronald T Raines
Journal:  Biochemistry       Date:  2004-03-09       Impact factor: 3.162

8.  Follistatin is induced by ionizing radiation and potentially predictive of radiosensitivity in radiation-induced fibrosis patient derived fibroblasts.

Authors:  Helen B Forrester; Alesia Ivashkevich; Michael J McKay; Trevor Leong; David M de Kretser; Carl N Sprung
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

9.  The Role of Activin A and B and the Benefit of Follistatin Treatment in Renal Ischemia-Reperfusion Injury in Mice.

Authors:  Doreen Y P Fang; Bo Lu; Susan Hayward; David M de Kretser; Peter J Cowan; Karen M Dwyer
Journal:  Transplant Direct       Date:  2016-06-06

10.  Activin in the brain modulates anxiety-related behavior and adult neurogenesis.

Authors:  Hiroshi Ageta; Akiko Murayama; Rika Migishima; Satoshi Kida; Kunihiro Tsuchida; Minesuke Yokoyama; Kaoru Inokuchi
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.